Combining RAS(ON) G12C-selective inhibitor with SHP2 inhibition sensitises lung tumours to immune checkpoint blockade
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Combining RAS(ON) G12C-selective inhibitor with SHP2 inhibition sensitises lung tumours to immune checkpoint blockade ; volume:15 ; number:1 ; day:25 ; month:9 ; year:2024 ; pages:1-17 ; date:12.2024
Nature Communications ; 15, Heft 1 (25.9.2024), 1-17, 12.2024
- Creator
-
Anastasiou, Panayiotis
Moore, Christopher
Rana, Sareena
Tomaschko, Mona
Pillsbury, Claire E.
Castro, Andrea de
Boumelha, Jesse
Mugarza, Edurne
Carné Trécesson, Sophie de
Mikolajczak, Ania
Blaj, Cristina
Goldstone, Robert
Smith, Jacqueline A. M.
Quintana, Elsa
Molina-Arcas, Miriam
Downward, Julian
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41467-024-52324-3
- URN
-
urn:nbn:de:101:1-2411302108148.507667098089
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:32 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Anastasiou, Panayiotis
- Moore, Christopher
- Rana, Sareena
- Tomaschko, Mona
- Pillsbury, Claire E.
- Castro, Andrea de
- Boumelha, Jesse
- Mugarza, Edurne
- Carné Trécesson, Sophie de
- Mikolajczak, Ania
- Blaj, Cristina
- Goldstone, Robert
- Smith, Jacqueline A. M.
- Quintana, Elsa
- Molina-Arcas, Miriam
- Downward, Julian
- SpringerLink (Online service)
Other Objects (12)
Mouse models and targeted therapies for RAS-driven tumours
Gamma tocotrienol targets tyrosine phosphatase SHP2 in mammospheres resulting in cell death through RAS/ERK pathway
Immune checkpoint therapy for solid tumours: clinical dilemmas and future trends
PD-1 blockade delays tumor growth by inhibiting an intrinsic SHP2/Ras/MAPK signalling in thyroid cancer cells
Combining Mechanisms of Growth Arrest in Solid Tumours: A Mathematical Investigation
Shp2 reguliert die Differenzierung intestinaler Epithelzellen
Integrative Oncology Approaches to Supporting Immune Checkpoint Inhibitor Treatment of Solid Tumours
Prospects for combining immune checkpoint blockade with PARP inhibition
Pediatric tumours: liver tumours
Combining gemcitabine with checkpoint kinase inhibitors to sensitize pancreatic tumors
Combining multiple spatial statistics enhances the description of immune cell localisation within tumours
Solid tumours showing oligoprogression to immune checkpoint inhibitors have the potential for abscopal effects
Mouse models and targeted therapies for RAS-driven tumours
Gamma tocotrienol targets tyrosine phosphatase SHP2 in mammospheres resulting in cell death through RAS/ERK pathway
Immune checkpoint therapy for solid tumours: clinical dilemmas and future trends
PD-1 blockade delays tumor growth by inhibiting an intrinsic SHP2/Ras/MAPK signalling in thyroid cancer cells
Combining Mechanisms of Growth Arrest in Solid Tumours: A Mathematical Investigation
Shp2 reguliert die Differenzierung intestinaler Epithelzellen
Integrative Oncology Approaches to Supporting Immune Checkpoint Inhibitor Treatment of Solid Tumours
Prospects for combining immune checkpoint blockade with PARP inhibition
Pediatric tumours: liver tumours
Combining gemcitabine with checkpoint kinase inhibitors to sensitize pancreatic tumors
Combining multiple spatial statistics enhances the description of immune cell localisation within tumours
Solid tumours showing oligoprogression to immune checkpoint inhibitors have the potential for abscopal effects
Mouse models and targeted therapies for RAS-driven tumours
Gamma tocotrienol targets tyrosine phosphatase SHP2 in mammospheres resulting in cell death through RAS/ERK pathway
Immune checkpoint therapy for solid tumours: clinical dilemmas and future trends
PD-1 blockade delays tumor growth by inhibiting an intrinsic SHP2/Ras/MAPK signalling in thyroid cancer cells
Combining Mechanisms of Growth Arrest in Solid Tumours: A Mathematical Investigation
Shp2 reguliert die Differenzierung intestinaler Epithelzellen
Integrative Oncology Approaches to Supporting Immune Checkpoint Inhibitor Treatment of Solid Tumours
Prospects for combining immune checkpoint blockade with PARP inhibition
Pediatric tumours: liver tumours
Combining gemcitabine with checkpoint kinase inhibitors to sensitize pancreatic tumors
Combining multiple spatial statistics enhances the description of immune cell localisation within tumours